Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Optimized CRISPR-Cas12a platform for combinatorial drop-out genetic screening (RNA-seq)

ABSTRACT: Optimized CRISPR-Cas12a platform for combinatorial drop-out genetic screening (RNA-seq)

PROVIDER: PRJNA592183 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10546800.fastq.gz	Fastqsanger.gz
	SRR10546801.fastq.gz	Fastqsanger.gz
	SRR10546802.fastq.gz	Fastqsanger.gz
	SRR10546803.fastq.gz	Fastqsanger.gz
	SRR10546804.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 29

Similar Datasets

Optimized CRISPR-Cas12a platform for combinatorial drop-out genetic screening (RNA-seq)

Project description:Combinatorial genetic perturbations have been utilized to identify synthetic sick/lethal genetic interactions for cancer drug target discovery. Current methods for high-throughput combinatorial genetic screening are inefficient and cumbersome. Here we developed a simple, robust, and high-performance CRISPR-Cas12a-based approach for unbiased, combinatorial genetic screening in cancer cells.

2020-06-08 | GSE141130 | GEO

Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform

Project description:Systematic mapping of genetic interactions and interrogation of the functions of sizeable genomic segments in mammalian cells represent important goals of biomedical research. To advance these goals, we present a CRISPR-based screening system for combinatorial genetic manipulation that employs co-expression of Cas9 and Cas12a nucleases and machine learning-optimized libraries of hybrid Cas9-Cas12a guide RNAs. This system, named CHyMErA (Cas Hybrid for Multiplexed Editing and Screening Applications), outperforms genetic screens using Cas9 or Cas12a editing alone. Application of CHyMErA to the ablation of mammalian paralog gene pairs reveals extensive genetic interactions and uncovers phenotypes normally masked by functional redundancy. Application of CHyMErA in a chemo-genetic interaction screen identifies genes that impact cell growth in response to mTOR pathway inhibition. Moreover, by systematically targeting thousands of alternative splicing events, CHyMErA identifies exons underlying human cell line fitness. CHyMErA thus represents an effective screening approach for genetic interaction mapping and the functional analysis of sizeable genomic regions, such as alternative exons.

2020-02-29 | GSE144078 | GEO

Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform

2020-01-28 | GSE144281 | GEO

Optimization of Cas12a for multiplexed genome- scale transcriptional activation

Project description:Cas12a CRISPR technology, unlike Cas9, allows for multiplexing guide RNAs from a single transcript, simplifying combinatorial perturbations. While Cas12a has been implemented for multiplexed knockout genetic screens, it has yet to be optimized for CRISPR activation (CRISPRa) screens in human cells. Here we develop a new Cas12a-based transactivation domain (TAD) recruitment system using the ALFA nanobody and demonstrate simultaneous activation of up to four genes. We screen a genome-wide library to identify modulators of growth and MEK inhibition, and we compare these results to those obtained with open reading frame (ORF) overexpression and Cas9-based CRISPRa. We find that the activity of multiplexed arrays is largely predictable from the best-performing guide and we provide criteria for selecting active guides. We anticipate that these results will greatly accelerate the exploration of gene function and combinatorial phenotypes at scale.

2023-05-08 | GSE230445 | GEO

Optimization of Cas12a for multiplexed genome- scale transcriptional activation

2023-05-09 | GSE231789 | GEO

Optimized metrics for combinatorial and orthogonal CRISPR screens

Project description:Optimized metrics for combinatorial and orthogonal CRISPR screens

| PRJNA889037 | ENA

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations

Project description:Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations

| PRJNA1083585 | ENA

Optimized metrics for combinatorial and orthogonal CRISPR screens

Project description:CRISPR-based gene perturbation enables unbiased investigations of single and combinatorial genotype-to-phenotype associations. In light of efforts to map combinatorial gene dependencies at scale, choosing an efficient and robust CRISPR-associated (Cas) nuclease is of utmost importance. Even though SpCas9 and AsCas12a are widely used for single, combinatorial, and orthogonal screenings, side-by-side comparisons remain sparse. Here, we systematically compared combinatorial SpCas9, AsCas12a, and CHyMErA in hTERT-immortalized retinal pigment epithelial cells and extracted performance-critical parameters for combinatorial and orthogonal CRISPR screens. Our analyses identified SpCas9 to be superior to enhanced and optimized AsCas12a, with CHyMErA being largely inactive in the tested conditions. Since AsCas12a contains RNA processing activity, we used arrayed dual-gRNAs to improve AsCas12a and CHyMErA applications. While this negatively influenced the effect size of combinatorial AsCas12a applications, it enhanced the performance of CHyMErA. This improved performance, however, was limited to AsCas12a dual-gRNAs, as SpCas9 gRNAs remained largely inactive. To avoid the use of hybrid gRNAs for orthogonal applications, we engineered the multiplex SpCas9-enAsCas12a system (multiSPAS) that avoids RNA processing for efficient orthogonal gene editing.

2023-05-10 | GSE215175 | GEO

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations (amplicon)

Project description:Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations (amplicon)

| PRJNA1083589 | ENA

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations (Nanopore)

Project description:Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations (Nanopore)

| PRJNA1083588 | ENA